Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
John Sampson
Duke University, Department: Neurosurgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Annias Immunotherapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Sampson has equity in Annias which has licensed intellectual property used in this project. As PI, he provides scientific oversight and supervision for the project.
Development of a Therapeutic for Brain Tumor Immunotherapy
PROJECT NARRATIVE Malignant primary brain tumors, like glioblastoma (GBM), are the most frequent cause of cancer death in children and young adults and account for more deaths than cancer of the kidney or melanoma. GBM remains uniformly lethal with an overall survival of <20 months despite aggressive surgery, incapacitating radiation, dose-limited chemotherapy and novel therapies like tumor-treating fields. This application focuses on replicating a small but randomized trial of a vaccine against GBM that resulted in half of the treated patients living almost 5 years, along with the addition of a novel anti-CD27 mAb that simultaneously depletes immunosuppressive regulatory T cells yet further enhances vaccine-induced immunity.
Filed on April 27, 2018.
Tell us what you know about John Sampson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
John Sampson filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| John Sampson | Duke University | Conflict of Interest | Annias Immunotherapeutics | Value cannot be readily determined |
| John Sampson | Duke University | Conflict of Interest | Annias Immunotherapeutics | Value cannot be readily determined |
| John Sampson | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| John Sampson | Duke University | Conflict of Interest | No entity at this time | Value cannot be readily determined |
| John Sampson | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.